| Schedule of extension warrants issued to affiliates |
Between
September 22, 2014, and August 16, 2016, the Company raised an aggregate principal amount of $6.0 million in Notes, which along
with $317,000 of interest thereon, were converted on September 21, 2016 into 1,263,406 shares of Common Stock at $5.00 per share.
Of the $6.0 million of Notes sold by the Company, $5.3 million were purchased by directors, an officer and greater than 5% shareholders
of the Company and converted into shares as follows.
| |
|
|
|
Principal Investment
in Convertible Notes |
|
|
Interest Earned
At conversion |
|
|
Shares Issued
on conversion |
|
| RSJ |
|
(1) |
|
$ |
2,100,000 |
|
|
|
122,200 |
|
|
|
444,454 |
|
| John Pappajohn |
|
(2) |
|
|
1,600,000 |
|
|
|
52,500 |
|
|
|
290,498 |
|
| Tierney Family Trust |
|
(3) |
|
|
640,000 |
|
|
|
46,600 |
|
|
|
137,328 |
|
| Follman Family Trust |
|
(4) |
|
|
550,000 |
|
|
|
20,400 |
|
|
|
114,074 |
|
| Robin Smith MD |
|
(5) |
|
|
100,000 |
|
|
|
3,900 |
|
|
|
20,776 |
|
| Geoffrey Harris |
|
(6) |
|
|
10,000 |
|
|
|
300 |
|
|
|
2,058 |
|
| George Carpenter |
|
(7) |
|
|
100,000 |
|
|
|
1,300 |
|
|
|
20,254 |
|
| Oman Ventures |
|
(8) |
|
|
200,000 |
|
|
|
20,400 |
|
|
|
44,089 |
|
| |
|
|
|
$ |
5,300,000 |
|
|
|
267,600 |
|
|
|
1,073,531 |
|
| |
(1) |
RSJ is a greater
than 10% shareholder. Michal Votruba, a Director for Life Sciences for the RSJ/Gradus Fund, joined our Board on July 30, 2015. |
| |
(2) |
John Pappajohn is
a member of the Board. He purchased $1,600,000 of Notes of which $200,000 were assigned to four accredited investors on September
6, 2015. Approximately $10,400 of the total interest was attributable to such transferred Notes, resulting in an aggregate
of 42,084 shares being issued upon the conversion of such transferred Notes. |
| |
(3) |
Thomas Tierney is
a trustee of the Tierney Family Trust. Mr. Tierney was a member of our Board between September 2016 and July 2017, and prior
to that, between February 2013 and May 2015. The Tierney Family Trust is a greater than 5% shareholder of the Company. |
| |
(4) |
Robert Follman is
a trustee of the Follman Family Trust and was a member of the Board through July 2017. |
| |
(5) |
Dr. Robin Smith
is the Chairman of the Board. |
| |
(6) |
Geoffrey Harris
is a member of the Board and Chairman of the Audit Committee. |
| |
(7) |
George Carpenter
is the CEO of the Company. |
| |
(8) |
Mark & Jill
Oman are the beneficial owners of Oman Ventures and were greater than 5% shareholders of the Company. |
|